417 related articles for article (PubMed ID: 15350937)
1. Adjuvant therapy for pancreatic cancer: an evolving paradigm.
Zhu AX; Clark JW; Willett CG
Surg Oncol Clin N Am; 2004 Oct; 13(4):605-20, viii. PubMed ID: 15350937
[TBL] [Abstract][Full Text] [Related]
2. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
Ghaneh P; Neoptolemos JP
Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant therapy following resection for pancreatic adenocarcinoma.
Brennan MF
Surg Oncol Clin N Am; 2004 Oct; 13(4):555-66, vii. PubMed ID: 15350934
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant therapy for pancreatic cancer: the Duke experience.
White RR; Tyler DS
Surg Oncol Clin N Am; 2004 Oct; 13(4):675-84, ix-x. PubMed ID: 15350941
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of unresectable locally advanced pancreatic cancer with combined radiotherapy and chemotherapy].
Jensen HA; Nielsen HO; Jensen JD; Fristrup CW; Nielsen M; Pfeiffer P
Ugeskr Laeger; 2008 Feb; 170(8):639-41. PubMed ID: 18364156
[TBL] [Abstract][Full Text] [Related]
6. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
[TBL] [Abstract][Full Text] [Related]
7. The case for routine use of adjuvant therapy in pancreatic cancer.
Kennedy EP; Yeo CJ
J Surg Oncol; 2007 Jun; 95(7):597-603. PubMed ID: 17230543
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant therapy for resectable pancreatic cancer.
Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
[TBL] [Abstract][Full Text] [Related]
10. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.
Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC
Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant treatments for resectable pancreatic cancer.
Ueno H; Kosuge T
J Hepatobiliary Pancreat Surg; 2008; 15(5):468-72. PubMed ID: 18836798
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
13. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
Miller RC; Iott MJ; Corsini MM
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy for pancreatic cancer: current status and future directions.
Xiong HQ; Abbruzzese JL
Surg Oncol Clin N Am; 2004 Oct; 13(4):737-49, xi. PubMed ID: 15350945
[TBL] [Abstract][Full Text] [Related]
15. The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure.
Ducreux M; Boige V; Goéré D; Deutsch E; Ezra P; Elias D; Malka D
Best Pract Res Clin Gastroenterol; 2007; 21(6):997-1014. PubMed ID: 18070700
[TBL] [Abstract][Full Text] [Related]
16. Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003.
Abrams RA; Yeo CJ
Surg Oncol Clin N Am; 2004 Oct; 13(4):621-38, ix. PubMed ID: 15350938
[TBL] [Abstract][Full Text] [Related]
17. The Virginia Mason approach to localized pancreatic cancer.
Picozzi VJ; Traverso LW
Surg Oncol Clin N Am; 2004 Oct; 13(4):663-74, ix. PubMed ID: 15350940
[TBL] [Abstract][Full Text] [Related]
18. Improved survival with adjuvant external-beam radiation therapy in lymph node-negative pancreatic cancer: a United States population-based assessment.
Artinyan A; Hellan M; Mojica-Manosa P; Chen YJ; Pezner R; Ellenhorn JD; Kim J
Cancer; 2008 Jan; 112(1):34-42. PubMed ID: 18000805
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer?
Pisters PW; Evans DB
Ann Surg; 2008 Aug; 248(2):152-3. PubMed ID: 18650622
[No Abstract] [Full Text] [Related]
20. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer.
Kosuge T; Kiuchi T; Mukai K; Kakizoe T;
Jpn J Clin Oncol; 2006 Mar; 36(3):159-65. PubMed ID: 16490736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]